CAR T-cell therapy for pleural mesothelioma: Rationale, preclinical development, and clinical trials - Lung Cancer
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight | Journal of Translational Medicine | Full Text
Recent chimeric antigen receptor-T cell (CAR-T)-based clinical trials... | Download Table
Frontiers | CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma | Neuroscience
Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts | EMBO Molecular Medicine
Frontiers | CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma | Neuroscience
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany | Gene Therapy
Frontiers | CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma | Neuroscience
Clinical Trials of CART Cells in China | Semantic Scholar
Smart Cell Therapies for Solid Cancers Ready to Move Toward Clinical Trials | UC San Francisco
Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme - Marei - 2021 - Cancer Medicine - Wiley Online Library
Clinical development of CAR T cell therapy in China: 2020 update | Cellular & Molecular Immunology
Driving CAR T cell translation forward
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy | NEJM
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy | NEJM
Clinical implication of cellular vaccine in glioma: current advances and future prospects | Journal of Experimental & Clinical Cancer Research | Full Text
As CAR-T advances into solid tumors, glioblastoma emerges as area of opportunity
Clinical development of CAR T cell therapy in China: 2020 update | Cellular & Molecular Immunology
TCR discovery - Current and future directions in CAR-T and TCR-T
CAR-T in solid tumors: Blazing a new trail through the brambles - ScienceDirect
The Promise of Chimeric Antigen Receptor T-Cell Therapy
Our Pipeline – Chimeric Therapeutics
